Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Syntimmune hired Dr. Jean-Paul Kress as chief executive officer and president. Previously, he was executive vice president and president, international, and head of global therapeutic operations at Biogen (BIIB).
About the Author Reprints
